Novo Nordisk A/S ADR (NY: NVO )

105.06 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
May 31, 2011
Form 6-K
Source: SEC/Edgar
May 30, 2011
Form 6-K
Source: SEC/Edgar
May 23, 2011
Form 6-K
Source: SEC/Edgar
May 16, 2011
Form 6-K
Source: SEC/Edgar
May 12, 2011
Form 6-K
Source: SEC/Edgar
May 09, 2011
Form 6-K
Source: SEC/Edgar
May 08, 2011
Form 6-K
Source: SEC/Edgar
May 04, 2011
Form 6-K
Source: SEC/Edgar
April 27, 2011
Form 6-K
Source: SEC/Edgar
April 27, 2011
Form 6-K
Source: SEC/Edgar
April 17, 2011
Form 6-K
Source: SEC/Edgar
April 10, 2011
Form 6-K
Source: SEC/Edgar
April 03, 2011
Form 6-K
Source: SEC/Edgar
March 31, 2011
Form 6-K
Source: SEC/Edgar
March 29, 2011
Form 6-K
Source: SEC/Edgar
March 28, 2011
Form 6-K
Source: SEC/Edgar
March 23, 2011
Form 6-K
Source: SEC/Edgar
March 21, 2011
Form 6-K
Source: SEC/Edgar
March 20, 2011
Form 6-K
Source: SEC/Edgar
March 13, 2011
Form 6-K
Source: SEC/Edgar
March 07, 2011
Form 6-K
Source: SEC/Edgar
February 28, 2011
Form 6-K
Source: SEC/Edgar
February 21, 2011
Form 6-K
Source: SEC/Edgar
February 15, 2011
Form 6-K
Source: SEC/Edgar
February 15, 2011
Form 6-K
Source: SEC/Edgar
February 14, 2011
Form 6-K
Source: SEC/Edgar
February 14, 2011
Form 6-K
Source: SEC/Edgar
February 14, 2011
Form 6-K
Source: SEC/Edgar
February 14, 2011
Form 20-F
Source: SEC/Edgar
February 13, 2011
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.